Literature DB >> 12960395

Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses.

Santanu Bose1, Niladri Kar, Ratan Maitra, Joseph A DiDonato, Amiya K Banerjee.   

Abstract

NF-kappaB is known to exert its antiviral innate immune response via the IFN-beta-induced Janus kinase/signal transducers and activators of transcription pathway. However, our current studies have demonstrated that activated NF-kappaB is capable of directly establishing an antiviral state independent of IFN or secreted soluble factor(s) against two highly pathogenic respiratory RNA viruses. Human parainfluenza virus type 3, a mildly cytopathic virus that induced NF-kappaB very early during infection was converted to a virulent virus after NF-kappaB inhibition. In contrast, a highly cytopathic virus, human respiratory syncytial virus that induced NF-kappaB late during infection, was converted to a mildly cytopathic virus after NF-kappaB induction before virus replication. This interconversion of cytopathic phenotypes of viruses after NF-kappaB modulation was further shown to be independent of IFN and soluble secreted factors(s). Moreover, tumor necrosis factor alpha (TNF-alpha) and IL-1beta elicited an antiviral response, which was NF-kappaB-dependent. Thus, NF-kappaB induction directly confers an essential innate antiviral response against human parainfluenza virus type 3 and respiratory syncytial virus, which is independent of IFN-inducible factor(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960395      PMCID: PMC196898          DOI: 10.1073/pnas.1832775100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Anti-inflammatory effect of adenovirus-mediated IkappaBalpha overexpression in respiratory epithelial cells.

Authors:  G Y Park; S Le; K H Park; C T Le; Y W Kim; S K Han; Y S Shim; C G Yoo
Journal:  Eur Respir J       Date:  2001-11       Impact factor: 16.671

4.  Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokine-independent manner.

Authors:  J Gao; S Choudhary; A K Banerjee; B P De
Journal:  Gene Expr       Date:  2000

5.  Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway.

Authors:  Karl W Thomas; Martha M Monick; Janice M Staber; Timor Yarovinsky; A Brent Carter; Gary W Hunninghake
Journal:  J Biol Chem       Date:  2001-10-30       Impact factor: 5.157

6.  Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription.

Authors:  S Choudhary; J Gao; D W Leaman; B P De
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Authors:  K A Fitzgerald; E M Palsson-McDermott; A G Bowie; C A Jefferies; A S Mansell; G Brady; E Brint; A Dunne; P Gray; M T Harte; D McMurray; D E Smith; J E Sims; T A Bird; L A O'Neill
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

8.  The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.

Authors:  M C Ferran; J M Lucas-Lenard
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

10.  IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK).

Authors:  X Li; M Commane; Z Jiang; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

View more
  34 in total

1.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Characterizing the Cellular Immune Response to Parainfluenza Virus 3.

Authors:  Paibel I Aguayo-Hiraldo; Reuben J Arasaratnam; Ifigeneia Tzannou; Manik Kuvalekar; Premal Lulla; Swati Naik; Caridad A Martinez; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

3.  Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants.

Authors:  Gillian Hughes; Michael P Murphy; Elizabeth C Ledgerwood
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

4.  Regulation of TLR3 Activation by S100A9.

Authors:  Su-Yu Tsai; Jesus A Segovia; Te-Hung Chang; Niraj K Shil; Swechha M Pokharel; T R Kannan; Joel B Baseman; Joan Defrêne; Nathalie Pagé; Annabelle Cesaro; Philippe A Tessier; Santanu Bose
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

5.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

6.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

7.  Activation of innate immune antiviral responses by Nod2.

Authors:  Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Victoria Frohlich; Kaoru Tominaga; Peter H Dube; Yan Xiang; Santanu Bose
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

8.  Retinoic acid inducible gene I activates innate antiviral response against human parainfluenza virus type 3.

Authors:  Ahmed Sabbah; Santanu Bose
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

9.  Anticancer oncolytic activity of respiratory syncytial virus.

Authors:  I Echchgadda; S Kota; I DeLa Cruz; A Sabbah; T Chang; R Harnack; V Mgbemena; B Chatterjee; S Bose
Journal:  Cancer Gene Ther       Date:  2009-05-15       Impact factor: 5.987

10.  Expression of an IKKgamma splice variant determines IRF3 and canonical NF-kappaB pathway utilization in ssRNA virus infection.

Authors:  Ping Liu; Muping Lu; Bing Tian; Kui Li; Roberto P Garofalo; Deborah Prusak; Thomas G Wood; Allan R Brasier
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.